PE/FITC/APC/Biotin-Conjugated BCMA Antibody for Cell Analysis

TNFRSF17 (BCMA, CD269) is a TNF receptor family member expressed almost exclusively on plasma cells, transmitting BAFF/APRIL survival signals. BCMA is the leading clinically validated target for multiple myeloma CAR-T therapy.

Order information

Catalog No.Product NameConjugateSizePrice (In USD)
GM-Tg-hg-T66693-Ab-3-PEAnti-Human TNFRSF17/BCMA/CD269 monoclonal antibody(mAb)(PE)PE25T
GM-Tg-hg-T66693-Ab-3-PEAnti-Human TNFRSF17/BCMA/CD269 monoclonal antibody(mAb)(PE)PE100T
GM-Tg-hg-T66693-Ab-3-PEAnti-Human TNFRSF17/BCMA/CD269 monoclonal antibody(mAb)(PE)PE500T
GM-Tg-hg-T66693-Ab-3-FITCAnti-Human TNFRSF17/BCMA/CD269 monoclonal antibody(mAb)(FITC)FITC25T
GM-Tg-hg-T66693-Ab-3-FITCAnti-Human TNFRSF17/BCMA/CD269 monoclonal antibody(mAb)(FITC)FITC100T
GM-Tg-hg-T66693-Ab-3-FITCAnti-Human TNFRSF17/BCMA/CD269 monoclonal antibody(mAb)(FITC)FITC500T
GM-Tg-hg-T66693-Ab-3-APCAnti-Human TNFRSF17/BCMA/CD269 monoclonal antibody(mAb)(APC)APC25T
GM-Tg-hg-T66693-Ab-3-APCAnti-Human TNFRSF17/BCMA/CD269 monoclonal antibody(mAb)(APC)APC100T
GM-Tg-hg-T66693-Ab-3-APCAnti-Human TNFRSF17/BCMA/CD269 monoclonal antibody(mAb)(APC)APC500T
GM-Tg-hg-T66693-Ab-3-BiotinAnti-Human TNFRSF17/BCMA/CD269 monoclonal antibody(mAb)(Biotin)Biotin25T, 100T, 500T

Description

TargetBCMA (specific biomarker for human plasma cell)
SpeciesHumanized
Expression platformMammalian cell
IsotypesHuman IgG
TaghFc
ConjugatePE / FITC / APC / Biotin
Size25T / 100T / 500T
Purity>=95% (SDS-PAGE)
Bioactivity validationBCMA binding, FACS in BCMA level test
ApplicationFACS and other Immunoassay for BCMA test
Products descriptionAnti-Human TNFRSF17/BCMA/CD269 monoclonal antibody(mAb)(PE/FITC/APC/Biotin) is a recombinant monoclonal antibody. It specifically recognizes BCMA (TNF receptor superfamily member 17, highly restricted to plasma cells). BCMA is a plasma cell marker. This antibody is validated by FACS for multiple-myeloma target assessment for BCMA CAR-T. It is recommended for multi-color flow cytometry panels to validate BCMA expression on patient plasma cells for BCMA CAR-T screening in CAR-T cell therapy manufacturing, QC and functional assessment.
Formulation & ReconstitutionLyophilized from sterile PBS, pH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.



<